| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenues: | ||||||
Total revenues | ||||||
3,669 | 6,574 | 4,962 | ||||
Operating expenses: | ||||||
Research and development | ||||||
44,330 | 48,788 | 31,644 | ||||
General and administrative | ||||||
18,952 | 12,674 | 5,551 | ||||
Total operating expenses | ||||||
63,282 | 61,462 | 37,195 | ||||
Loss from operations | ||||||
-59,613 | -54,888 | -32,233 | ||||
Other income | ||||||
2,203 | 1,607 | 165 | ||||
Net loss and comprehensive loss | ||||||
-57,410 | -53,281 | -32,068 | ||||
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | ||||||
-1.71 | -2.64 | -6.17 | ||||
Weighted-average number of common shares outstanding, basic and diluted (in shares) | ||||||
33,556 | 20,199 | 5,196 | ||||
Collaboration revenue | ||||||
Total revenues | ||||||
3,669 | 4,932 | - | ||||
Grant revenue | ||||||
Total revenues | ||||||
- | 1,642 | - | ||||